Rosario Pivonello
Endocrinology — Federico II University Hospital, Italy
Rosario Pivonello
LeadR Profile
Endocrinology
Subspecialties: Public Health - Pharmacy - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 701
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 28
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Study to Evaluate Atumelnant in Adults with Congenital Adrenal Hyperplasia 2024-519579-24-00 — safety, adrenal hyperplasia, congenital, hyperplasia | Phase 3 | Not yet recruiting | 2026 |
| A study to learn about the safety and effectiveness of CRN04894 on participants 2024-514846-35-00 — safety, adrenal hyperplasia, congenital, therapeutics, hyperplasia | Phase 2 | Recruiting | 2025 |
| LOng COvid COmorbidities Andrological Reproductive Sexual Dysfunctions in Patients Recovered From COVID 19 NCT05379556 — premature ejaculation, research design, masturbation, quality of life, comorbidity, erectile dysfunction, sars-cov-2, life style, follicle stimulating hormone, body mass index, serum, estradiol, ageusia, body height, prostaglandins, prostate, physical examination, self-assessment, ejaculation, sexual abstinence, hormones, testosterone, anosmia, covid-19, prolactin, varicocele, prevalence, body weight, alprostadil, fires, wounds and injuries, plastics, testis, infections, post-acute covid-19 syndrome, female, male | N/A | Recruiting | 2022 |
| Rec LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men NCT04189133 — chorionic gonadotropin, hypogonadism, safety, luteinizing hormone, infertility, hormones, testosterone, gonadotropins, therapeutics, infertility, male, steroids, menotropins, male, men | Phase 2 | Recruiting | 2022 |
LeadR Networks
Main global connection map